These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 6083915)
1. [Behavior of the intrinsic fibrinolytic system in healthy blood donors]. Huyke R; Vogel G; Kulle M Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):484-91. PubMed ID: 6083915 [TBL] [Abstract][Full Text] [Related]
2. [Relationship of age, sex, body weight, smoking, blood lipids and fibrinolytic activities in healthy subjects]. Xiong X; Wang Z; Zhao S Hunan Yi Ke Da Xue Xue Bao; 1999; 24(1):65-7. PubMed ID: 11938745 [TBL] [Abstract][Full Text] [Related]
3. Sex differences in the determinants of fibrinolytic activity. MacCallum PK; Cooper JA; Howarth DJ; Meade TW; Miller GJ Thromb Haemost; 1998 Mar; 79(3):587-90. PubMed ID: 9531046 [TBL] [Abstract][Full Text] [Related]
4. Protein C activity in healthy volunteers--influence of age, sex, smoking and oral contraceptives. Tait RC; Walker ID; Islam SI; McCall F; Conkie JA; Wight M; Mitchell R; Davidson JF Thromb Haemost; 1993 Aug; 70(2):281-5. PubMed ID: 8236135 [TBL] [Abstract][Full Text] [Related]
5. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters. Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650 [TBL] [Abstract][Full Text] [Related]
6. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis. Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167 [TBL] [Abstract][Full Text] [Related]
7. [Evaluation of plasma prothrombin fragment 1+2 in healthy donors and thrombotic diseases]. Kawai Y; Shiomi T; Ono H; Katagiri H; Uchida R; Sugisaki N; Watanabe K Rinsho Byori; 1994 Jan; 42(1):57-62. PubMed ID: 8107284 [TBL] [Abstract][Full Text] [Related]
9. Reproducibility of fibrinolytic response to venous occlusion in healthy subjects. Stegnar M; Mavri A Thromb Haemost; 1995 Mar; 73(3):453-7. PubMed ID: 7667828 [TBL] [Abstract][Full Text] [Related]
10. Fibrinolytic response to venous occlusion compared to physical stress test in young patients with coronary artery disease. Nikfardjam M; Graf S; Beckmann R; Hornykewycz S; Koller-Strametz J; Binder BR; Huber K Thromb Haemost; 1999 Sep; 82 Suppl 1():80-4. PubMed ID: 10695493 [TBL] [Abstract][Full Text] [Related]
11. Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers: smoking, thrombin, and vascular responses in vivo. Lang NN; Gudmundsdóttir IJ; Boon NA; Ludlam CA; Fox KA; Newby DE J Am Coll Cardiol; 2008 Jul; 52(1):33-9. PubMed ID: 18582632 [TBL] [Abstract][Full Text] [Related]
12. Coagulation and fibrinolysis are in balance after moderate exercise in middle-aged participants. Menzel K; Hilberg T Clin Appl Thromb Hemost; 2009; 15(3):348-55. PubMed ID: 19022797 [TBL] [Abstract][Full Text] [Related]
13. [The characteristics of the blood anticoagulation system and of urinary fibrinolysis in healthy newborn infants]. Samsygina GA; Vykhristiuk OF Akush Ginekol (Sofiia); 1990; 29(4):31-7. PubMed ID: 2267979 [TBL] [Abstract][Full Text] [Related]
14. Activity of coagulation and fibrinolytic system components in the vein thrombus. Guzowski A; Gacko M; Worowska A; Kowalewski R; Ostapowicz R; Ploński A Adv Med Sci; 2006; 51():205-7. PubMed ID: 17357310 [TBL] [Abstract][Full Text] [Related]
15. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism]. Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355 [TBL] [Abstract][Full Text] [Related]
16. [Coagulation/fibrinolysis disorders in the elderly]. Deguchi A; Wada H; Shiku H; Hamaguchi H; Kawamura Y Rinsho Byori; 2000 Mar; 48(3):217-21. PubMed ID: 10804828 [TBL] [Abstract][Full Text] [Related]
17. Behaviour and quantitation of extrinsic (tissue-type) plasminogen activator in human blood. Kluft C; Jie AF; Allen RA Thromb Haemost; 1983 Aug; 50(2):518-23. PubMed ID: 6356452 [TBL] [Abstract][Full Text] [Related]
18. "Studies on the levels of fibrinolytic-activity with special reference to its range of activity on various substrates (including coagulation factors) in healthy controls". I. Bharadwaj TP; Sen NK J Assoc Physicians India; 1971 Jan; 19(1):43-8. PubMed ID: 5560025 [No Abstract] [Full Text] [Related]
19. Increased global fibrinolytic capacity as a clue for activated fibrinolysis in pre-eclampsia. Sucak GT; Acar K; Sucak A; Kirazli S; Haznedar R Blood Coagul Fibrinolysis; 2006 Jul; 17(5):347-52. PubMed ID: 16788310 [TBL] [Abstract][Full Text] [Related]
20. Effects of venous occlusion and local exercise on fibrinolytic activity and clotting time of blood. Malathi A; Parulkar VG Indian J Physiol Pharmacol; 1985; 29(3):175-7. PubMed ID: 3836195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]